logo
Lucien Pagès Merges with AIPR

Lucien Pagès Merges with AIPR

LONDON — The glow has scarcely faded from the monumental party Lucien Pagès threw for his 50th birthday and he's already celebrating another watershed with Wednesday morning's announcement that his public relations agency Lucien Pagès Communication is forming a joint venture with Adam Iezzi's London-based agency AIPR. Backing the union is The Independents, the global design, production and PR giant, which acquired LPC last December. The terms of the transaction were not disclosed.
For the UK, Pagès' original Scrabble-lettered logo has been re-configured by M/M Paris to incorporate AIPR ('You can make more words now,' says Lucien), because he thought it was important for Iezzi to maintain his identity in the local market. Elsewhere, the venture will be under the Pagès umbrella.
Pagès and Iezzi first encountered each other in 2010, in an article in 10Men, '10 PR Gurus You Should Meet.' They were on facing pages. 'I was trying to be funny,' Iezzi recalls, 'and I just sounded stupid, and Lucien's answers sounded really intelligent. I thought I have to raise my game.' He was already working with Jonathan Anderson and APC at that point. Iezzi helped APC become a new client for Pagès, and Anderson would later join the LPC roster in Paris when the designer signed up with Loewe.
The two agencies eventually shared nine clients, including APC, Loewe and Zara. 'If Adam wasn't in London, I would have opened there a long time ago,' Pagès concedes. 'It's strategically important. The best magazines in English speak to the world. But I never thought to do anything in London because Adam was there. It can be competitive working with other agencies, but never with Adam. It was always a good match of personalities.' Iezzi agrees. 'I always felt Lucien had my back.'
It may have even got to the point, Iezzi conjectures, where people thought they were the same person. Not for a moment, says anyone who knows them both well. Still, the confusion makes sense when he adds that 'the merger is formalising something that already exists.'
The fallout from Brexit surely helped catalyse the alliance. They opened up their businesses to each other. Pagès had to sort out his own acquisition first, but once that was done, he wasted no time in persuading The Independents CEO Isabelle Chouvet that AIPR would be an asset.
Pagès and Iezzi share an old-school faith in the power of public relations. 'It's all gone a bit clickbait-y now, but Lucien and I are still excited to place a beautiful magazine piece.'
Pagès adds that a shared dry-as-a-bone sense of humour is a big help. When the finance and legal people needed a codename to keep negotiations confidential, Lucien came up with 'Project Confide in Me.' More than a favourite Kylie Minogue track, it was also a camp little tip of the cap to Adam's Melbourne roots. So it will simply have to be on the karaoke when LPC and AIPR's team, all 100 of them, meet during men's fashion week in June to celebrate their union.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ciara and Her Daughter Sienna Twin in Power Suits at the Inaugural Black Women in Music Dinner
Ciara and Her Daughter Sienna Twin in Power Suits at the Inaugural Black Women in Music Dinner

Yahoo

time33 minutes ago

  • Yahoo

Ciara and Her Daughter Sienna Twin in Power Suits at the Inaugural Black Women in Music Dinner

Ciara and her eight-year-old daughter Sienna Wilson made the case for mother-daughter coords on Tuesday at The Connie Orlando Foundation's inaugural Black Women in Music Dinner in Los Angeles. The mononymous singer received the Avant-Garde award at the event. For the red carpet occasion, Ciara opted for suited styling, giving menswear an edgy spin with feminine touches throughout. The 'Level Up' artist opted for tailored black trousers, which coordinated with the singer's structured blazer. More from WWD Aimee Lou Wood Reunites With Patrick Schwarzenegger in New Campaign, Talks Astrology Fashion and Red Carpet Style The Best Beauty Moments at Gotham TV Awards 2025: Carrie Coon, Gabriela Hearst, Julio Torres and More Queen Letizia of Spain Embraces Burgundy Trend in Bleis Madrid Suit for Royal Engagement With King Felipe VI Ciara's blazer jacket featured fabric contrast with a silky sheen fabric for the sharp lapels set against the softer sheath fabric of the blazer. The blazer featured a cinched waist for added silhouette definition and rounded shoulders with long sleeves. Beneath the blazer, Ciara wore a crisp, collared white shirt with a silk black tie and a metallic silver tie clip. The singer's look was recreated in a miniaturized version for her eight-year-old daughter, who wore the exact same suited look with a pair of black kitten heel shoes. Ciara shares Sienna with husband Russell Wilson. Menswear, particularly suited looks, for women reached an apex between 2024 and 2025. Culturally significant figures like former Vice President Kamala Harris, as well as royal women like Queen Letizia of Spain and Kate Middleton, have embraced the power suit to mainstream relevance. Its ripple effect has been felt globally, with London-based brands 'expanding their offerings to cater to women's tailoring, with special care to detail and design,' WWD's Hikmat Mohammed reported in August 2024. For Ciara, the coordinated look with her daughter exemplifies much more than the trendy power suit for women. The coordinated red carpet moment also served as a reminder of the ways in which the singer enriches her daughter's life with fashion to sentimental ends. 'I definitely plan to collect things for her,' the singer told WWD in an interview from March 2018. 'I was in the closet the other day and I was putting on some heels and Russ was like, 'SiSi's [her daughter Sienna] gonna have those.' She was sitting around, so we were joking like, you're gonna have those when I get older — or when she gets older,' she said, adding, 'I definitely plan to keep a lot of cool things for her, especially jewelry pieces.' View Gallery Launch Gallery: Ciara and Russell Wilson's Chic Couple Shoe Style [PHOTOS] Best of WWD Mia Threapleton's Red Carpet Style Through the Years [PHOTOS] Princess Charlene of Monaco's Grand Prix Style Through the Years: Louis Vuitton, Akris and More, Photos Princess Charlene's Monaco Grand Prix Style Evolution at Full Speed: Shades of Blue in Louis Vuitton, Playful Patterning in Akris and More

SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy

Yahoo

timean hour ago

  • Yahoo

SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy

VANCOUVER, British Columbia & TOKYO & WALTHAM, Mass., June 08, 2025--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Therapeutics Corporation (TSE 4883; "Modalis"), a CRISPR-based epigenome editing therapeutics company focused on rare genetic diseases, today announced a strategic collaboration to develop an innovative therapy for FSHD, a debilitating muscular disorder affecting approximately 1 million individuals worldwide. The novel therapy leverages Modalis's proprietary CRISPR-GNDM® (Guide Nucleotide-Directed Modulation) technology, which can dynamically modulate gene expression without introducing double-strand DNA breaks. SOLVE FSHD will provide strategic funding to support the development of Modalis's MDL-103 program. MDL-103 is an innovative therapeutic solution that continuously suppresses the expression of the DUX4 gene, the toxic disease-causing gene for FSHD, which becomes abnormally activated due to epigenetic changes in the D4Z4 repeat region on chromosome 4. MDL-103 is designed to have durable activity over long periods of time under the control of a strong, muscle-specific promoter, and is delivered to the muscles of patients using a muscle-tropic AAV delivery system. Modalis's CRISPR-GNDM® technology has the potential to transform the treatment of FSHD by epigenetically silencing the expression of DUX4. "SOLVE FSHD is pleased to partner with Modalis and to add them to our diverse portfolio of collaborators that are advancing potential therapies for FSHD," stated Eva Chin, Executive Director of SOLVE FSHD. "SOLVE FSHD identified Modalis as a company committed to finding a cure for this debilitating condition. We were impressed by their unique approach to targeting the epigenetic cause of FSHD, using a platform technology that has shown promise in other neuromuscular diseases. We believe that the support from SOLVE FSHD will allow Modalis to accelerate the advancement of MDL-103 into clinical trials." "We are delighted to be working in partnership with SOLVE FSHD and greatly appreciate the invaluable support for the development of MDL-103," said Haru Morita, CEO of Modalis. "This strategic collaboration is a strong validation of Modalis's CRISPR-GNDM® technology and our MDL-103 program. As a pioneer in this technology, we have demonstrated promising long-term drug efficacy in mouse models, shown durable target engagement and safety in non-human primates, and exhibited excellent biodistribution in neuromuscular disorders. We believe that MDL-103, which incorporates CRISPR-GNDM® technology with a muscle tropic AAV delivery system, has significant potential as a breakthrough treatment for FSHD." About SOLVE FSHD SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD. Established by renowned Canadian entrepreneur and philanthropist, Chip Wilson, the Wilson family has committed $100 million to kick-start funding into projects that support the organizations' mission to solve FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD, visit About Modalis Therapeutics Corporation Modalis was founded in 2016 and conducts research and development activities in Massachusetts, USA. Modalis is a pioneering leader in the field of epigenetic medicine. Modalis develops therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS diseases, and cardiomyopathies. Modalis's proprietary CRISPR-GNDM® technology is capable of specifically up or down modulating the expression of disease-relevant genes without introducing double-strand DNA breaks. For more information, visit View source version on Contacts SOLVE FSHDAlexandra Grant, House of Wilsonalexandrag@ Modalis Therapeutics CorporationCorporate Planning Departmentmedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Sam Altman's Eyeball-Scanning Identification Tech Expands to UK
Sam Altman's Eyeball-Scanning Identification Tech Expands to UK

Bloomberg

timean hour ago

  • Bloomberg

Sam Altman's Eyeball-Scanning Identification Tech Expands to UK

Tools for Humanity, a startup co-founded by OpenAI 's Sam Altman, is rolling out its eyeball-scanning Orb devices to the UK as part of a global expansion of the company's novel identification services. Starting this week, people in London, Manchester, Birmingham, Cardiff, Belfast and Glasgow will be able to scan their eyes using Tools for Humanity's proprietary orb device, the company said in a statement on Monday.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store